94759-32-7

Basic information

• Product Name: 3-Piperidinemethanol, 1-methyl-, 4-methylbenzenesulfonate (ester)
• CAS NO: 94759-32-7
• Molecular Formula: C14H21NO3S
• Molecular Weight: 283.392
• Mol File: 94759-32-7.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: 3-Piperidinemethanol, 1-methyl-, 4-methylbenzenesulfonate (ester)(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Piperidinemethanol, 1-methyl-, 4-methylbenzenesulfonate (ester)(94759-32-7)
• EPA Substance Registry System: 3-Piperidinemethanol, 1-methyl-, 4-methylbenzenesulfonate (ester)(94759-32-7)

Safety Data

• Hazardous Substances Data: 94759-32-7(Hazardous Substances Data)

Upstream product

• 7583-53-1 1-methyl-3-hydroxymethylpiperidine 
• 98-59-9 p-toluenesulfonyl chloride 

Downstream Products

• 1042152-71-5 3-(iodomethyl)-1-methylpiperidine 
• 459452-04-1 2-Methyl-5-(1-methyl-piperidin-3-ylmethoxy)-1H-indole-3-carboxylic acid benzyl ester 

Relevant articles and documents

BICYCLIC COMPOUNDS AS INHIBITORS OF PD1/PD-L1 INTERACTION/ACTIVATION

The compounds of Formula I is described herein along with their polymorphs, stereoisomers, tautomers, prodrugs, solvates, and pharmaceutically acceptable salts thereof. The compounds described herein, their polymorphs, stereoisomers, tautomers, prodrugs, solvates, and pharmaceutically acceptable salts thereof are bicyclic compounds that are inhibitors of PD-1/PD-L1 interaction/activation.

CARBOXAMIDE INHIBITORS OF IRAK4 ACTIVITY

The present invention relates to carboxamide inhibitors of IRAK4 of formula (I) and provides compositions comprising such inhibitors, as well as methods therewith for treating IRAK4-mediated or -associated conditions or diseases.

IH-indol-5-YL-piperazin-1-YL-methanone derivatives

The present invention relates to compounds of formula I and their pharmaceutically acceptable salts wherein in formula I is: wherein R1 to R4 are as defined in the description and claims. The compounds of the present invention are us